What's new

Human medicines European public assessment report (EPAR): Temodal, temozolomide, Date of authorisation: 26/01/1999, Revision: 39, Status: Authorised

Human medicines European public assessment report (EPAR): Temodal, temozolomide, Date of authorisation: 26/01/1999, Revision: 39, Status: Authorised

Apr 22, 2025 - 16:39
 0
Human medicines European public assessment report (EPAR): Temodal, temozolomide, Date of authorisation: 26/01/1999, Revision: 39, Status: Authorised
Human medicines European public assessment report (EPAR): Temodal, temozolomide, Date of authorisation: 26/01/1999, Revision: 39, Status: Authorised
Read More

Tags:

Previous Article

Roche to swell US footprint with sweeping $50B investment, furthering pharma's o...

Next Article

Impact Confections launches fizzy sour candy

Related Posts

Human medicines European public assessment report (EPAR): Quviviq, daridorexant, Date of authorisation: 29/04/2022, Revision: 9, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 9, 2025  0

Orphan designation: Octreotide acetate Treatment of acromegaly, 05/08/2013 Withdrawn

Orphan designation: Octreotide acetate Treatment of acr...

Mar 21, 2025  0

Human medicines European public assessment report (EPAR): Penbraya, Meningococcal groups A, C, W, Y conjugate and group B vaccine (recombinant, adsorbed), Date of authorisation: 14/11/2024, Status: Withdrawn

Human medicines European public assessment report (EPAR...

Feb 9, 2025  0